NEW YORK (GenomeWeb News) – Life Technologies said today that Zymera has licensed its quantum dot intellectual property portfolio.

Zymera plans to use the Qdot nanocrystals to create self-illuminating quantum dot products that will be used in in vivo imaging, biomarker discovery, and in biosensing applications. Zymera's self-illumination technology uses bioluminescence resonance energy transfer, to transfer light from bioluminescent proteins, such as luciferase, onto quantum dots.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.